BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lestón Pinilla L, Ugun-Klusek A, Rutella S, De Girolamo LA. Hypoxia Signaling in Parkinson's Disease: There Is Use in Asking "What HIF?". Biology (Basel) 2021;10:723. [PMID: 34439955 DOI: 10.3390/biology10080723] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Fouché B, Turner S, Gorham R, Stephenson EJ, Gutbier S, Elson JL, García-Beltrán O, Van Der Westhuizen FH, Pienaar IS. A Novel Mitochondria-Targeting Iron Chelator Neuroprotects Multimodally via HIF-1 Modulation Against a Mitochondrial Toxin in a Dopaminergic Cell Model of Parkinson's Disease. Mol Neurobiol 2023;60:749-67. [PMID: 36357615 DOI: 10.1007/s12035-022-03107-8] [Reference Citation Analysis]
2 Park M, Shin HA, Duong VA, Lee H, Lew H. The Role of Extracellular Vesicles in Optic Nerve Injury: Neuroprotection and Mitochondrial Homeostasis. Cells 2022;11. [PMID: 36496979 DOI: 10.3390/cells11233720] [Reference Citation Analysis]
3 Fiore NJ, Tamer-Mahoney JD, Beheshti A, Nieland TJF, Kaplan DL. 3D biocomposite culture enhances differentiation of dopamine-like neurons from SH-SY5Y cells: A model for studying Parkinson's disease phenotypes. Biomaterials 2022;290:121858. [PMID: 36272218 DOI: 10.1016/j.biomaterials.2022.121858] [Reference Citation Analysis]
4 Jiang L, Zhong Z, Huang J, Bian H, Huang W. Monocytohigh-density lipoprotein ratio has a high predictive value for the diagnosis of multiple system atrophy and the differentiation from Parkinson’s disease. Front Aging Neurosci 2022;14:1035437. [DOI: 10.3389/fnagi.2022.1035437] [Reference Citation Analysis]
5 Barlier C, Ribeiro MM, Jung S, del Sol A. RNetDys: identification of disease-related impaired regulatory interactions due to SNPs.. [DOI: 10.1101/2022.10.08.511312] [Reference Citation Analysis]
6 Guo M, Ji X, Liu J. Hypoxia and Alpha-Synuclein: Inextricable Link Underlying the Pathologic Progression of Parkinson's Disease. Front Aging Neurosci 2022;14:919343. [DOI: 10.3389/fnagi.2022.919343] [Reference Citation Analysis]
7 Tada S, Choudhury ME, Kubo M, Ando R, Tanaka J, Nagai M. Zonisamide Ameliorates Microglial Mitochondriopathy in Parkinson’s Disease Models. Brain Sciences 2022;12:268. [DOI: 10.3390/brainsci12020268] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]